Delivery Order 36F79719D0246-36C77026N0018
Award Date 3/9/26
Potential Completion Date 3/20/26
Potential Value $710K
Funding Federal Agency
Contracting Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Raleigh, NC 27615, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price delivery order was awarded by the Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company that specializes in developing and commercializing therapies for neurological disorders. The $478,860.00 contract is for the delivery of pharmaceutical products, specifically Levodopa 42mg inhalation capsules used to treat Parkinson's disease symptoms. The contract is associated with Acorda's Federal Supply Schedule (FSS) contract with the VA, valued...
- The Department of Veterans Affairs (VA) Veterans Health Administration and Veterans Integrated Service Network 12 have awarded a firm fixed price delivery order to Acorda Therapeutics, Inc., a biotechnology company, for the delivery of Levodopa, a medication used to treat Parkinson's disease symptoms. The $158,963.04 delivery order was issued under Acorda's Federal Supply Schedule (FSS) contract for Pharmaceuticals and Drugs (FSS-61-IB). Acorda has previously provided pharmaceutical products...
- This is a federal contract award to Merck Sharp & Dohme LLC, doing business as Merck, a major pharmaceutical manufacturer. The contract, with a ceiling value of $21,035.74, is a delivery order under Merck's General Services Administration (GSA) Federal Supply Schedule 61-IB for Pharmaceuticals and Drugs. The contract is for the drug SOTATERCEPT, with a performance period ending on January 10, 2025. The contracting agency is the Veterans Integrated Service Network 10 (VISN 10), a civilian...
- This is a federal contract award from the U.S. Department of Veterans Affairs (VA) to Acorda Therapeutics, Inc., a biotechnology company specializing in neurological therapies. The contract, valued at $478,860.00, is a Firm Fixed Price Delivery Order under Acorda's Federal Supply Schedule (FSS) contract with the VA. The contract is for the supply of Levodopa 42mg inhalation capsules, a medication used to treat Parkinson's disease, to the VA's Veterans Health Administration and Veterans...
- The Department of Veterans Affairs Veterans Health Administration awarded Neurocrine Biosciences, Inc. a $630,480.96 firm fixed price delivery order against the company's GSA Schedule contract for Pharmaceuticals and Drugs. The contract will provide pharmaceutical products to support VHA operations within Veterans Integrated Service Network 9, with performance taking place in San Diego, California from November 19-24, 2020. No set-aside designation or subcontractors were indicated. The...
- The Department of Veterans Affairs, Veterans Integrated Service Network 5, awarded a $30.6K delivery order to UCB Pharma, Inc. (Ucb, Inc.) on March 4, 2026, for the supply of Zilbrysq 32.4 mg pharmaceutical product. This firm fixed-price delivery order, with an ultimate completion date of March 17, 2026, operates as a derivative instrument under UCB Pharma's Federal Supply Schedule contract for Pharmaceuticals and Drugs (FSS-61-IB). The award carries no set-aside designation and represents...
- The Department of Veterans Affairs Veterans Health Administration awarded a $697,550 delivery order to Neurocrine Biosciences, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The order calls for Neurocrine to supply various pharmaceutical items to meet clinical medication order processing system needs at Veterans Integrated Service Network 12 facilities located in San Diego, California. Performance will take place from April 7 to 14, 2021. The firm fixed price order was...
- The Department of Veterans Affairs Veterans Health Administration awarded a $840,641 delivery order to Neurocrine Biosciences, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The contract calls for Neurocrine to provide VALBENAZINE to Veterans Integrated Service Network 12 in support of VA-VHA programs. Performance will take place in San Diego, California over a period of one week from January 3-10, 2020. The firm fixed price contract utilizes Neurocrine's existing...
- The Department of Veterans Affairs Veterans Health Administration awarded Neurocrine Biosciences, Inc. a $579,765.60 firm fixed price delivery order against the company's GSA Schedule Pharmaceuticals and Drugs contract. The contract calls for Neurocrine to provide VALBENAZINE to Veterans Integrated Service Network 12 in support of the VA-VHA's healthcare programs. Performance will take place in San Diego, California over a one week period in June 2020. No subcontractors or set aside designations...
- This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,779.47 firm fixed-price delivery order is for the supply of NAMZARIC 28 MG-10 MG CAPSULE 30S, a medication used to treat Alzheimer's disease. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 between AmerisourceBergen and the DLA Troop Support Medical, which serves as a primary...